Physician profile
Constance Bridges
NPI 1487005567
$1,201.83
in general payments reported to CMS, 2019-2025
23 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $356 · 2022: $197 · 2023: $227 · 2024: $165 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $227.71 | 2021-2025 | |
| Amgen INC. | $132.20 | 2021-2022 | |
| Novo Nordisk INC | $120.43 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Abbott Laboratories | $96.31 | 2022-2025 | Freestyle Libre 3 |
| Pfizer INC. | $80.27 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.92 | 2021-2025 | |
| Lilly USA, LLC | $55.58 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $48.22 | 2023 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.64 | 2023-2025 | Jardiance |
| Boston Scientific Corporation | $45.60 | 2022-2025 | Watchman Access System |
| Edwards Lifesciences Corporation | $39.78 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.54 | 2022-2023 | Xifaxan |
| Janssen Pharmaceuticals, INC | $28.06 | 2022 | |
| Novartis Pharmaceuticals Corporation | $26.87 | 2024 | |
| Amarin Pharma, INC. | $19.71 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $18.14 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $17.30 | 2021 | |
| Ascensia Diabetes Care US INC. | $15.59 | 2024 | |
| Bausch Health US, LLC | $14.90 | 2022 | |
| Sumitomo Pharma America, INC. | $14.82 | 2023 | Gemtesa |
| Exact Sciences Corporation | $14.62 | 2025 | Cologuard Collection Kit |
| Arbor Pharmaceuticals, INC. | $14.45 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.17 | 2025 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constance Bridges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.